Provenance du réseau au premier degré de Damon R Race
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race.
2
| Holding Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Damon R Race via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Nabgen, Inc. | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 2 |
Sectorielle
Opérationnelle
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Chengwen Li | 2 |
| Richard Limehouse | 1 |
- Bourse
- Insiders
- Damon R Race
- Connexions Sociétés
